Follow us on YouTube Follow us on Twitter

Join Our Mailing List »

BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.  

BHI's vision is to transform the Central Maryland region into a leading global bio-health entrepreneurial and commercialization hub. Learn more »

Prev
Next

Ingenuity Systems, a 15-year veteran of the biological software business, showed today that you can make money not just by …

MedImmune has acquired Ann Arbor-based AlphaCore Pharma, creating another exit for a local up-and-coming start-up. MedImmune, the global biologics research and …

Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an asset purchase agreement to acquire the Healthcare …

The Biotechnology Industry Organization (BIO) is pleased to announce the election of Rachel King, President and CEO, GlycoMimetics, Inc, as …

BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding …

Date: Wednesday, May 8th, 2013 9:30am-5:00pm Location: Morgan, Lewis & Bockius Conference Center, 1111 Pennsylvania Ave., NW Washington, DC 20004-2541 National Brain Tumor Society …

- Multiple SBIR/STTR Submission Deadlines Quickly Approaching - BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth …

BHI Partners

 

Join Our Mailing List

Name: Email: